US Stock MarketDetailed Quotes
GRNAW GREENLIGHT BIOSCIENCES HOLDINGS PBC C/WTS 02/02/2027 (TO PUR COM)
- 0.022
- 0.0000.00%
Close Jul 25 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.022Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.06052wk High0.00P/B0Float Cap0.00652wk Low--Dividend TTM0Shs Float1.425Historical High--Div YieldTTM0.00%Amplitude0.006Historical Low--Avg Price1Lot Size
About GREENLIGHT BIOSCIENCES HOLDINGS PBC C/WTS 02/02/2027 (TO PUR COM) Company
GreenLight Biosciences Holdings PBC is a pre-commercial stage synthetic biology company with a proprietary cell-free ribonucleic acid production platform for the discovery, development, and commercialization of high-performing products to promote healthier plants, foods, and people. The company is developing RNA products for plant and life science applications to advance crop management, plant protection, animal health, vaccine development, and pandemic preparation.
Company Profile
SymbolGRNAW
Company NameGREENLIGHT BIOSCIENCES HOLDINGS PBC C/WTS 02/02/2027 (TO PUR COM)
CEODr. Andrey J Zarur, PhD
MarketNASDAQ
Employees312
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Company Executives
- Name
- Position
- Salary
- Carole Cobb, M.B.A.
- Chief Operating Officer
- 1.30M
- Clay Mitchell
- Director, President, Chief Financial Officer and Secretary
- --
- Nina Thayer
- General Counsel and Chief Compliance Officer
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg